US FDA monitoring impact of SARS-CoV-2 mutations

The FDA has alerted clinical laboratory staff that it is monitoring the potential impact of SARS-CoV-2 mutations, including the UK variant.

Related Keywords

United Kingdom ,Stephen Hahn ,Mesabiotech Accula ,Drug Administration ,ஒன்றுபட்டது கிஂக்டம் ,ஸ்டீபன் ஹான் ,